A Study to Assess SOM230 in Patients With Pituitary Cushing's Disease

Clinical trial NCT00088608 · COMPLETED

Trial details

NCT number: NCT00088608
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cushing's Syndrome

Start date: 2004-04-01
Primary completion: 2006-06-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.